Dr Brad S Schneider, PhD
Chief Microbiology Officer
Brad S Schneider is a seasoned public health professional with extensive experience conducting high-impact scientific, public health, and capacity building programs in the US, Africa, and Asia. With over 18 years of experience in the field, he has worked with a broad range of pathogens, including Ebola, avian influenza, and West Nile viruses, in a diversity of settings, including some of the most logistically challenging regions of the world.
Dr. Schneider is adept at managing multi-laboratory research teams to successfully complete complex, multidisciplinary projects with shifting priorities and loosely defined deliverables, requiring close coordination with US government agencies and host country communities and ministries.
Working in both the government (e.g. Centers for Disease Control) and private sector (e.g. Institut Pasteur and Metabiota, Inc) he has employed diplomacy and cultural sensitivity to establish productive international networks that deliver high-quality, impactful technical products.
He is a leader in the identification, development, and management of new capabilities and processes, working across scientific functional groups, to strategically integrate scientific expertise and technologies to support the implementation of biomedical programs, providing insights, innovation, and structure. His activities have been funded by US Agency for International Development (USAID), the National Institutes of Health (NIH), Defense Advanced Research Projects Agency (DARPA), the Defense Threat Reduction Agency (DTRA) Cooperative Biological Engagement Program (CBEP), the Department of Homeland Security, the Department of State, and Google.org.
Dr. Schneider developed country-level operational plans and guided the global diagnostic strategy that is currently deployed in over 25 countries for the USAID Emerging Pandemic Threats PREDICT program, a highly successful $100 million endeavor focused on strengthening capacities in developing countries to prevent, detect, and control infectious diseases in animals and people, with an emphasis on early identification of, and response to, dangerous pathogens before they can become significant threats to human health.
Dr. Schneider has served globally in leadership and advisory roles as a member of academic, ethics, review and search committees. During his scientific career, he has published over 65 peer-reviewed manuscripts on a broad spectrum of infectious disease topics, including viral, bacterial, and parasitic pathogens.